Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oregon DHEA bill

This article was originally published in The Tan Sheet

Executive Summary

School employees would be prohibited from knowingly endorsing or suggesting the ingestion of any performance-enhancing supplement to students under a bill recently introduced by Oregon Senate President Peter Courtney, D-Salem. The legislation, SB 517, also contains provisions that would partner the Department of Education with voluntary organizations to develop educational programs for students to prevent the use of steroids and performance-enhancing supplements. The Act is declared an "emergency" measure and would punish violators with three months imprisonment or $500 or both. The bill passed the Senate Education and General Government subcommittee on March 13, according to Courtney's staff. Sen. Courtney introduced a similar bill in 2005. It passed the Senate but was defeated in the House...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100316

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel